![Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines - ScienceDirect Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X19303354-ga1.jpg)
Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines - ScienceDirect
![Viruses | Free Full-Text | Factors Associated with Dog Rabies Immunization in Changsha, China: Results of a Cross-Sectional Cluster Survey, 2015–2021 Viruses | Free Full-Text | Factors Associated with Dog Rabies Immunization in Changsha, China: Results of a Cross-Sectional Cluster Survey, 2015–2021](https://www.mdpi.com/viruses/viruses-15-00138/article_deploy/html/images/viruses-15-00138-g003.png)
Viruses | Free Full-Text | Factors Associated with Dog Rabies Immunization in Changsha, China: Results of a Cross-Sectional Cluster Survey, 2015–2021
![Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial - The Lancet Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial - The Lancet](https://www.thelancet.com/cms/attachment/c25c6965-11a9-4fc8-984c-ba5308e52eee/gr1_lrg.gif)
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial - The Lancet
![Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/figures/mm7118a2-F-large.gif?_=74286)
Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR
![People with ongoing occupational exposure to lyssaviruses are recommended to receive booster doses of rabies vaccine | The Australian Immunisation Handbook People with ongoing occupational exposure to lyssaviruses are recommended to receive booster doses of rabies vaccine | The Australian Immunisation Handbook](https://immunisationhandbook.health.gov.au/sites/default/files/styles/full_wide_lg_hi/public/2021-09/Figure-Booster-algorithm-ongoing-risk-to-rabies-210921.png?itok=izasWNTC)